HK1223627A1 - '- '- '-脫氧- ', '-二氟四氫尿苷的合成途徑 - Google Patents

'- '- '-脫氧- ', '-二氟四氫尿苷的合成途徑

Info

Publication number
HK1223627A1
HK1223627A1 HK16111983.8A HK16111983A HK1223627A1 HK 1223627 A1 HK1223627 A1 HK 1223627A1 HK 16111983 A HK16111983 A HK 16111983A HK 1223627 A1 HK1223627 A1 HK 1223627A1
Authority
HK
Hong Kong
Prior art keywords
difluorotetrahydrouridines
deoxy
synthetic route
route
synthetic
Prior art date
Application number
HK16111983.8A
Other languages
English (en)
Inventor
Hyeong-Wook Choi
Steven Mathieu
Frank Fang
Bryan Matthew Lewis
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of HK1223627A1 publication Critical patent/HK1223627A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0201Oxygen-containing compounds
    • B01J31/0209Esters of carboxylic or carbonic acids
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0234Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds
    • B01J31/0235Nitrogen containing compounds
    • B01J31/0237Amines
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0234Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds
    • B01J31/0235Nitrogen containing compounds
    • B01J31/0244Nitrogen containing compounds with nitrogen contained as ring member in aromatic compounds or moieties, e.g. pyridine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00Separation of optically-active compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • C07H1/06Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK16111983.8A 2013-10-29 2016-10-18 '- '- '-脫氧- ', '-二氟四氫尿苷的合成途徑 HK1223627A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361896703P 2013-10-29 2013-10-29
PCT/US2014/062874 WO2015066162A1 (en) 2013-10-29 2014-10-29 Synthetic route to 2'-deoxy-2',2'-difluorotetrahydrouridines

Publications (1)

Publication Number Publication Date
HK1223627A1 true HK1223627A1 (zh) 2017-08-04

Family

ID=51982743

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16111983.8A HK1223627A1 (zh) 2013-10-29 2016-10-18 '- '- '-脫氧- ', '-二氟四氫尿苷的合成途徑

Country Status (20)

Country Link
US (3) US9834576B2 (zh)
EP (1) EP3063164B1 (zh)
JP (1) JP6427567B2 (zh)
KR (1) KR102272773B1 (zh)
CN (1) CN105683209B (zh)
AU (1) AU2014342402B2 (zh)
BR (1) BR112016008855B1 (zh)
CA (1) CA2926734C (zh)
ES (1) ES2712877T3 (zh)
HK (1) HK1223627A1 (zh)
IL (1) IL244849B (zh)
MX (1) MX363205B (zh)
MY (1) MY176465A (zh)
NZ (1) NZ718607A (zh)
PH (1) PH12016500683B1 (zh)
RU (1) RU2681939C2 (zh)
SA (1) SA516371019B1 (zh)
SG (1) SG11201602614XA (zh)
WO (1) WO2015066162A1 (zh)
ZA (1) ZA201602315B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2926734C (en) 2013-10-29 2022-03-15 Otsuka Pharmaceutical Co., Ltd. Synthetic route to 2'-deoxy-2',2'-difluorotetrahydrouridines
US11224610B2 (en) 2018-09-19 2022-01-18 Otsuka Pharmaceutical Co., Ltd. Low dose combination CDA substrate drug/cedazuridine with extended administration
MX2022004271A (es) * 2019-10-08 2022-06-09 Otsuka Pharma Co Ltd 2'-desoxi-2',2'-difluoro tetrahidruridina de alta pureza y metodos para su preparacion.
CN113402573B (zh) * 2020-07-31 2023-06-20 集美大学 一种鞣质类化合物及其提取方法和应用
WO2022254457A1 (en) * 2021-05-29 2022-12-08 Msn Laboratories Private Limited, R&D Center An improved process for the preparation of (4r)-1-[(2r,4r,5r)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl) oxolan-2-yl]-4-hydroxy-1,3-diazinan-2one and its intermediate compounds
TWI821074B (zh) * 2021-12-25 2023-11-01 台灣神隆股份有限公司 製備希達路里定(cedazuridine)的方法
US20230271996A1 (en) * 2021-12-25 2023-08-31 Scinopharm Taiwan, Ltd. Process for preparing cedazuridine

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
US5223608A (en) 1987-08-28 1993-06-29 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
US4965374A (en) 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
FR2682112B1 (fr) 1991-10-08 1993-12-10 Commissariat A Energie Atomique Procede de synthese d'acide ribonucleique (arn) utilisant un nouveau reactif de deprotection.
US5371210A (en) 1992-06-22 1994-12-06 Eli Lilly And Company Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US5521294A (en) 1995-01-18 1996-05-28 Eli Lilly And Company 2,2-difluoro-3-carbamoyl ribose sulfonate compounds and process for the preparation of beta nucleosides
US6001994A (en) 1995-12-13 1999-12-14 Eli Lilly And Company Process for making gemcitabine hydrochloride
EP0876149A4 (en) 1995-12-22 2001-09-26 Univ East Carolina PROCESS FOR THE TREATMENT OF CHARACTERIZED DISORDERS BY OVEREXPRESSION OF CYTIDINE-DESAMINASE OR DESOXYCYTIDINE-DESAMINASE
US5760208A (en) 1996-08-14 1998-06-02 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Process to prepare pyrimidine nucleosides
EP1348712B1 (en) 2000-11-29 2011-05-04 Mitsui Chemicals, Inc. Processes and intermediates in the synthesis of L-thymidine
FI112640B (fi) 2000-12-22 2003-12-31 Kone Corp Hissin turvalaite
JP5225271B2 (ja) * 2006-06-21 2013-07-03 イーライ リリー アンド カンパニー ゲムシタビンアミドプロドラッグの結晶形、その組成物および使用
JO2778B1 (en) * 2007-10-16 2014-03-15 ايساي انك Certain vehicles, installations and methods
CA2926734C (en) 2013-10-29 2022-03-15 Otsuka Pharmaceutical Co., Ltd. Synthetic route to 2'-deoxy-2',2'-difluorotetrahydrouridines

Also Published As

Publication number Publication date
PH12016500683A1 (en) 2016-05-30
US20180072768A1 (en) 2018-03-15
US11028119B2 (en) 2021-06-08
US20200123189A1 (en) 2020-04-23
US10526362B2 (en) 2020-01-07
CA2926734C (en) 2022-03-15
JP6427567B2 (ja) 2018-11-21
IL244849A0 (en) 2016-05-31
RU2681939C2 (ru) 2019-03-14
RU2016115523A (ru) 2017-12-04
CN105683209A (zh) 2016-06-15
EP3063164B1 (en) 2018-12-05
AU2014342402B2 (en) 2018-11-01
RU2016115523A3 (zh) 2018-06-05
KR102272773B1 (ko) 2021-07-02
SG11201602614XA (en) 2016-05-30
SA516371019B1 (ar) 2018-01-23
BR112016008855A2 (zh) 2017-08-01
IL244849B (en) 2019-10-31
MX2016005596A (es) 2016-12-09
MX363205B (es) 2019-03-13
EP3063164A1 (en) 2016-09-07
AU2014342402A1 (en) 2016-04-21
US20160237107A1 (en) 2016-08-18
ZA201602315B (en) 2019-07-31
JP2017500281A (ja) 2017-01-05
KR20160083021A (ko) 2016-07-11
MY176465A (en) 2020-08-11
WO2015066162A1 (en) 2015-05-07
NZ718607A (en) 2019-10-25
PH12016500683B1 (en) 2016-05-30
ES2712877T3 (es) 2019-05-16
CA2926734A1 (en) 2015-05-07
CN105683209B (zh) 2019-03-08
BR112016008855B1 (pt) 2023-01-17
US9834576B2 (en) 2017-12-05

Similar Documents

Publication Publication Date Title
HK1222846A1 (zh) 取代的苄基吡唑
HK1221717A1 (zh) 取代的苄基吡唑
GB2515794B (en) Improvements Relating to Vehicles
HRP20171890T1 (hr) Supstituirani imidazopiridazini
HK1223627A1 (zh) '- '- '-脫氧- ', '-二氟四氫尿苷的合成途徑
EP2968338A4 (en) NEW USES
EP2956141A4 (en) NEW USES
HK1223362A1 (zh) 取代的吡唑並吡啶胺
GB2516136B (en) Colenterazine analogs
HK1220972A1 (zh) 取代的噻唑並嘧啶
IL246271A0 (en) Converted piperidinyl-tetrahydroquinolines
HK1214222A1 (zh) 三輪車
DK2805823T4 (en) Plastrør i mindst to lag
GB201322641D0 (en) Railway Points
GB201300324D0 (en) Improvements to letter-plates
HK1214219A1 (zh) 三輪車
AU5095P (en) FAC01 Corymbia maculata
GB2511577B (en) Carrying structure
AU352352S (en) Locomotive
AU352351S (en) Locomotive
ZA201308430B (en) Reboundable traffic selineator
GB201318339D0 (en) Machine to machine architecture